SPLENECTOMY IN HODGKIN'S DISEASE: NO THERAPEUTIC BENEFITNEWCOMER LN; CADMAN EC; PROSNITZ LR et al.1982; AMERICAN JOURNAL OF CLINICAL ONCOLOGY; ISSN 512273; USA; DA. 1982; VOL. 5; NO 4; PP. 393-397; BIBL. 12 REF.Article

LONG TERM REMISSIONS WITH COMBINED MODALITY THERAPY FOR ADVANCED HODGKIN'S DISEASE.PROSNITZ LR; FARBER LR; FISCHER JJ et al.1976; CANCER; U.S.A.; DA. 1976; VOL. 37; NO 6; PP. 2826-2833; BIBL. 20 REF.Article

A VASCULAR NECROSIS OF BONE IN HODGKIN'S DISEASE PATIENTS TREATED WITH COMBINED MODALITY THERAPYPROSNITZ LR; LAWSON JP; FRIEDLANDER GE et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 12; PP. 2793-2797; BIBL. 14 REF.Article

THE USEFULNESS OF THE LUKES-COLLINS CLASSIFICATION IN IDENTIFYING SUBSETS OF DIFFUSE HISTIOCYTIC LYMPHOMA RESPONSIVE TO CHEMOTHERAPYNEWCOMER LN; NERENBERG MI; CADMAN EC et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 50; NO 3; PP. 439-443; BIBL. 12 REF.Article

CURATIVE POTENTIAL OF COMBINED MODALITY THERAPY FOR ADVANCED HODGKIN'S DISEASEFARBER LR; PROSNITZ LR; CADMAN EC et al.1980; CANCER; ISSN 0008-543X; USA; DA. 1980; VOL. 46; NO 7; PP. 1509-1517; BIBL. 24 REF.Article

BONE INVOLVEMENT IN HODGKIN'S DISEASENEWCOMER LN; SILVERSTEIN MB; CADMAN EC et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 49; NO 2; PP. 338-342; BIBL. 23 REF.Article